This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Algeta To Host Capital Markets Days

OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --

Intended for US media only

Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will host Capital Markets
Days this week in Oslo, London and New York.

Event summaries and guest speaker details are provided below.

Oslo, 18 November 10:00am-2:00pm (CET)
KS-Agenda Møtesenter, Haakon VII's gate 9

  * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology,
    University Hospital of Oslo, Norway
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

London, 19 November 10:00am-2:00pm (GMT)
Holborn Bars 2(nd) Floor, 138-142 Holborn

  * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology,
    Head Urologic Oncology, University of Colorado, Denver, USA
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

New York, 21 November 12.30pm-4:30pm (EDT)
Parker Meridien, 118 West 57(th) Street

  * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University
    Medical Center, Durham, North Carolina, USA
  * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic
    Urology Clinics, Myrtle Beach, South Carolina, USA

The  event in New  York will be  webcast via www.algeta.com, where presentations
will also be made available.


                                      ###

For further information, please contact:

 Mike Booth                             +1 646 410 1884

 Communications & Corporate Affairs     ir@algeta.com



 Media enquiries:

 Mark Swallow                           +44 207 638 9571

 Citigate Dewe Rogerson                 mark.swallow@citigatedr.co.uk



 Kari Watson                            +1 781 235 3060

 MacDougall Biomedical Communications   kwatson@macbiocom.com



 Investor enquiries:

 Tricia Truehart                        +1 646 378 2953

 The Trout Group                        ttruehart@troutgroup.com


About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit
www.algeta.com.




Press release: http://hugin.info/134655/R/1743766/586643.pdf

[HUG#1743766]

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs